Calculating and comparing impact

Criticism of cost-effectiveness analysis

Criticism of the RCT-based approach

  • Growth and the case against randomista development
    • An argument that research on and advocacy for economic growth in low- and middle-income countries is more cost-effective than the things funded by proponents of randomized controlled trials development. (60 mins - if you’re short on time, read Sections 1-3)
  • Q&A with Elie Hassenfeld
    • Elie, the CEO and co-founder of GiveWell, discusses his organization’s latest research, his views on economic growth, and what he’s changed his mind on lately. (60 mins.)


New Comment